2.5707
前日終値:
$2.57
開ける:
$2.56
24時間の取引高:
25,586
Relative Volume:
0.15
時価総額:
$18.29M
収益:
$2.90M
当期純損益:
$87.91M
株価収益率:
0.1647
EPS:
15.6103
ネットキャッシュフロー:
$-26.93M
1週間 パフォーマンス:
-0.38%
1か月 パフォーマンス:
+15.11%
6か月 パフォーマンス:
+82.39%
1年 パフォーマンス:
-48.10%
Traws Pharma Inc Stock (TRAW) Company Profile
TRAW を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
TRAW
Traws Pharma Inc
|
2.5899 | 18.31M | 2.90M | 87.91M | -26.93M | 15.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.74 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
640.57 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
444.54 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.40 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.00 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Traws Pharma Inc Stock (TRAW) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-03-01 | 開始されました | Ladenburg Thalmann | Buy |
| 2021-05-18 | 開始されました | Guggenheim | Buy |
| 2018-03-01 | 繰り返されました | H.C. Wainwright | Buy |
| 2018-01-17 | ダウングレード | Maxim Group | Buy → Hold |
| 2017-10-09 | 開始されました | H.C. Wainwright | Buy |
| 2017-04-27 | 開始されました | Laidlaw | Buy |
| 2015-07-01 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2015-05-05 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Traws Pharma Inc (TRAW) 最新ニュース
Why ETFs are accumulating Traws Pharma Inc. (0T20) stockIndex Update & Fast Exit/Entry Strategy Plans - newser.com
Visualizing Traws Pharma Inc. stock with heatmapsTrade Performance Summary & Consistent Income Trade Ideas - newser.com
Measuring Traws Pharma Inc.’s beta against major indicesWatch List & Fast Gaining Stock Strategy Reports - newser.com
What the charts say about Traws Pharma Inc. todayExit Point & Stepwise Trade Signal Guides - newser.com
Using RSI to spot recovery in Traws Pharma Inc.2025 Top Decliners & Weekly Top Gainers Alerts - newser.com
Is Traws Pharma Inc. (0T20) stock supported by free cash flowJuly 2025 Intraday Action & Verified Swing Trading Watchlists - newser.com
Is Traws Pharma Inc. (0T20) stock testing key supportJuly 2025 Closing Moves & Stepwise Entry and Exit Trade Signals - newser.com
Live market analysis of Traws Pharma Inc.2025 Support & Resistance & Advanced Technical Signal Analysis - newser.com
What technical models suggest about Traws Pharma Inc.’s comebackEarnings Growth Report & Risk Controlled Daily Plans - newser.com
Will Traws Pharma Inc. (0T20) stock extend growth storyJuly 2025 Fed Impact & Consistent Profit Alerts - newser.com
Price action breakdown for Traws Pharma Inc.July 2025 Weekly Recap & Fast Entry and Exit Trade Plans - newser.com
Is Traws Pharma Inc. forming a reversal patternMarket Activity Report & High Accuracy Investment Signals - newser.com
Traws Pharma (NASDAQ:TRAW) Upgraded at Wall Street Zen - Defense World
Tick level data insight on Traws Pharma Inc. volatilityPortfolio Gains Summary & Breakout Confirmation Alerts - newser.com
Technical signs of recovery in Traws Pharma Inc.July 2025 Summary & Accurate Technical Buy Alerts - newser.com
Is a relief rally coming for Traws Pharma Inc. holdersWeekly Trend Recap & Comprehensive Market Scan Insights - newser.com
ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials - MarketScreener
2025-10-30 | ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials | NDAQ:TRAW | Press Release - Stockhouse
Advanced analytics toolkit walkthrough for Traws Pharma Inc.Earnings Risk Report & Fast Gain Stock Tips - newser.com
How Traws Pharma Inc. stock reacts to inflationary pressuresWeekly Trade Report & Verified Technical Trade Signals - newser.com
Traws Pharma Inc (TRAW) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):